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Book Reviews
doi: 10.1377/hlthaff.2013.0499
Drug
Dilemmas
BY CRAIG REINARMAN
Drugs and Drug Policy: What
Everyone Needs to Know
By Mark A.R. Kleiman, Jonathan P.
Caulkins, and Angela Hawken
New York (NY): Oxford University Press,
2011
234 pp., $16.95
These are not happy days
for drug prohibition. The
United States has the
world’s highest incarcer-
ation rate—in large part
because of the more than
500,000 drug offenders
currently in prison. More than 700,000
citizens are arrested annually for
marijuana possession. Some 60,000
Mexicans have been killed in drug war
violence. Yet the flow of drugs is un-
impeded. Sixteen thousand Americans
died of overdoses last year, and teen
drug use remains little affected.
During the past two decades, activists
created syringe exchange programs in
150 US cities to reduce the spread of
HIV/AIDS.Medicalmarijuana lawshave
been passed in nineteen states and
Washington, D.C. Voters in Colorado
and Washington passed marijuana le-
galization. And polls show that a major-
ity of Americans support these trends.
Reformers have forced open the space
for a real drug policy debate.
The authors of Drugs and Drug Policy:
What Everyone Needs to Know use this
space to expose myths, speak inconven-
ient truths, and nudge the debate away
from ideology toward evidence. The
reader wouldn’t know it from the book’s
clichéd cover: marijuana with a pipe, a
razor blade with chopped lines of co-
caine, and the predictable pile of cash
—all presented like a still life of a cartel
kingpin’s coffee table.But the text inside
paints amorenuancedpicture of aworld
where damage from legal drugs dwarfs
that from illicit drugs. The authors are
refreshingly candid about the trade-offs
and limitations of drug policy, and
through a series of brief answers
to 143 questions, they provide a well-
written and generally fair-minded sum-
mary of the vast literatures bearing on
drug problems.
According to the authors, “most peo-
ple who use abusable drugs do so in a
reasonably controlled fashion,” while
most “of the roughly 3 million depen-
dent users…are struggling,” poor, and
“criminally active.” The authors add,
however, that “policies shape the risks”:
The links between hard drug abuse, pov-
erty, and property crime are largely “a
consequence of illegality.”
Legalization would decrease crime,
but the authors also believe it would
yield unacceptable increases in drug
abuse. However, that has not happened
under decriminalization policies in the
Netherlands and Portugal. This argu-
ment assumes that legalization leads
only to an unregulated market, but that
is not what most reformers propose.
The authors do not focus on culture,
character, and everyday-life engage-
ments that keep most drug users from
addiction—nor the trauma, pain, and
deprivation that underlie most hard
cases. Instead, they generally see drug
users ashomo economicus forwhompric-
es determine demand. They recognize
the value, and the limitations, of all
types of treatment. And they offer many
ideas on how to make treatment more
effective, although their favorite is to jail
addicts when they slip up in treatment.
The book wisely acknowledges that
law enforcementhas limits and that con-
ventional supply reduction strategies
are based on “the illusion that the drug
problem is caused by the drugs…rather
than by the desire for those drugs.” Yet
they remain comfortable with a range of
repressive measures, including drug
testing employees to deter “off the job
drug use” and reengineering addicts’
immune systems to block drugs, as long
as those measures are “effective.”
Reasonable people can disagree about
how to balance efficacy and the basic
rights of drug-using citizens; however,
these questions become more pressing
when race is considered. Late in the
book, the authors admit that racial fears
have been detrimental to rational drug
policy and that punitive prohibition has
had a racially disparate impact. Yet they
argue that this is not because of institu-
tional racism, but because African
American dealers more often sell drugs
on the street, where they are more vul-
nerable to arrest. This ignores all of
the other ways in which discrimination
is baked into drug law enforcement. The
authors do acknowledge that “spending
$200,000 on incarceration to punish a
$250 transaction” is absurd.
The book ends with three sets of rec-
ommendations. A “consensus list” in-
cludes focusing treatmenton thosemost
in need and expanding opiate substitu-
tion therapy. A “pragmatist list” 1sug-
gests: “Stop punishing former dealers
and recovering addicts” by denying ac-
cess to services and higher education;
lock up fewer people; and embrace harm
reduction strategies. And the “bridge
too far list” contains higher taxes on
alcohol, regulated marijuana sales,
and research on themany potential ben-
efits of banned drugs. The authors give
no overall conclusion, but a line from
the first chapter works for this reviewer:
“Drug control thus resembles drug tak-
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ing: all well and good inmoderation, but
liable to slide into harmful excess.” ▪ Craig Reinarman (craigr@ucsc.edu) is a professor of
sociology and legal studies at the University of
California, Santa Cruz, and coauthor of Cocaine
Changes: The Experience of Using and Quitting
(Temple University Press, 1991) and Crack in
America: Demon Drugs and Social Justice
(University of California Press, 1997).
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